β-Blocker Dialyzability and Mortality in Older Patients Receiving Hemodialysis

This study does raise caution, but as the authors indicate, causality is different to determine as there was not random allocation of β-Blocker exposure. PMID: : Risk of acute kidney injury associated with the use of fluoroquinolones Outcomes of In-Hospital Cardiopulmonary Resuscitation in Maintenance Dialysis Patients Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficileInfection
Source: Nephrology Now - Category: Urology & Nephrology Authors: Tags: Chronic Kidney Disease Clinical Nephrology Hemodialysis Source Type: research